---
title: "3003 HSN Code | HSN Code for Mixed medicaments, therapeutic use in India"
description: "Know more about 3003 HSN Code with BUSY Accounting - HSN Tariff, GST Rates and case laws related to chapter 3003 covering Mixed medicaments, therapeutic use."
canonical: "https://busy.in/hsn/sub-chapter-3003/"
---

# HSN Sub-chapter 3003: Mixed medicaments, therapeutic use

Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale

Part of [Chapter 30: Pharmaceutical Products](https://busy.in/hsn/chapter-30/).

- Current GST rate: 5%
- Earlier GST rate: 12%

## HSN codes

| Code | Title |
| --- | --- |
| 30031000 | [Penicillins or Streptomycins](https://busy.in/hsn/hsn-30031000/) |
| 30032000 | [Other Antibiotics](https://busy.in/hsn/hsn-30032000/) |
| 30033100 | [Medicaments Containing Insulin](https://busy.in/hsn/hsn-30033100/) |
| 30033900 | [Other Medicaments Containing Hormones](https://busy.in/hsn/hsn-30033900/) |
| 30034000 | [Medicaments: Atropine & Salts (Retail)](https://busy.in/hsn/hsn-30034000/) |
| 30034100 | [Ephedrine/Salt Containing Drugs](https://busy.in/hsn/hsn-30034100/) |
| 30034200 | [Pseudoephedrine/Salt Containing Drugs](https://busy.in/hsn/hsn-30034200/) |
| 30034300 | [Medicaments Containing Norephedrine or Its Salts](https://busy.in/hsn/hsn-30034300/) |
| 30034900 | [Other alkaloids and derivatives](https://busy.in/hsn/hsn-30034900/) |
| 30036000 | [Medicaments Containing Antimalarial Active Principles](https://busy.in/hsn/hsn-30036000/) |
| 30039011 | [Ayurvedic Medicaments](https://busy.in/hsn/hsn-30039011/) |
| 30039012 | [Unani Medicaments](https://busy.in/hsn/hsn-30039012/) |
| 30039013 | [Siddha Medicaments](https://busy.in/hsn/hsn-30039013/) |
| 30039014 | [Mixtures of Medicaments Including Antibiotics](https://busy.in/hsn/hsn-30039014/) |
| 30039015 | [Mixtures of Medicaments for Therapy Including Antibiotics](https://busy.in/hsn/hsn-30039015/) |
| 30039021 | [Menthol crystals](https://busy.in/hsn/hsn-30039021/) |
| 30039022 | [Milk of Magnesia](https://busy.in/hsn/hsn-30039022/) |
| 30039031 | [Bovine Albumin (Animal Origin Drugs)](https://busy.in/hsn/hsn-30039031/) |
| 30039032 | [Merbromine](https://busy.in/hsn/hsn-30039032/) |
| 30039033 | [Calcium Sennoside](https://busy.in/hsn/hsn-30039033/) |
| 30039034 | [Anaesthetic Agents for Medicine](https://busy.in/hsn/hsn-30039034/) |
| 30039035 | [Aluminium Hydroxide Gel](https://busy.in/hsn/hsn-30039035/) |
| 30039036 | [Ketamine](https://busy.in/hsn/hsn-30039036/) |
| 30039090 | [Medicaments (excl. 3002/3005/3006), Mixed, Not Retail: Other](https://busy.in/hsn/hsn-30039090/) |

## Frequently asked questions

### What products are classified under HSN 3003

It includes Mixed medicaments, therapeutic use

### How are warranty replacements of Mixed medicaments, therapeutic use handled?

If replacement is without consideration under a pre‑agreed warranty, issue a delivery challan and reference the original invoice/contract. If consideration is charged, raise a tax invoice. Keep serial/lot details for traceability.

### Any special steps when selling Mixed medicaments, therapeutic use through an e‑commerce platform?

Ensure registration requirements are met and reconcile the operator’s TCS statements with your GSTR‑2B/3B. Map SKU descriptions to HSN to reduce mismatches and returns.

### Can I claim ITC on inputs and services used for Mixed medicaments, therapeutic use?

If your outward supply of Mixed medicaments, therapeutic use is taxable, ITC is generally available (Sections 16–17) except blocked credits (e.g., personal use, motor vehicles in most cases). For exempt supplies, proportionate reversal is required under Rule 42/43.

### How do I bill a kit or combo that includes Mixed medicaments, therapeutic use?

Prefer separate lines per item with its HSN so each component follows its own tax treatment. If it is a naturally bundled supply, identify the principal supply and tax the whole bundle accordingly.

### What are the e‑way bill and e‑invoice points while moving Mixed medicaments, therapeutic use?

Generate an e‑way bill when the consignment value exceeds ₹50,000, unless exempted for the transaction. E‑invoicing depends on turnover (AATO threshold as notified) for B2B supplies, not on the item itself.

## India's trade performance: HSN Sub-Chapter 3003 (FY 2024-25)

Source: TradeStat EIDB, Ministry of Commerce & Industry. Values in ₹ Crore (FY 2018-19 to FY 2024-25).

- Exports: ₹2,750 Cr (−5.93% YoY) — 0.0743% of India's total exports
- Imports: ₹961 Cr (+7.61% YoY) — 0.0158% of India's total imports
- Trade balance: ₹1,789 Cr (Surplus); surplus rank #140 of 1233 sub-chapters
- Share of Chapter 30: 1.32% of its exports; import side 3.81%
- Rank within Chapter 30: #3 of 6 by export value; import-side #4

### Key metrics

- Export CAGR: 3.92% (FY 2018-19 to FY 2024-25, 7 fiscal years)
- National export rank: #212 of 1233 sub-chapters by export value (FY 2024-25)
- Peak growth year: +19.88% in FY 2021-22
- Contribution to Ch. 30: 1.32% of its exports (FY 2024-25)

## India export-import trade statistics: HSN Sub-Chapter 3003

7-year export and import data, FY 2018-19 to FY 2024-25, in ₹ Crore. Source: Ministry of Commerce & Industry, TradeStat EIDB.

| FY | Exports (₹ Cr) | Exp share | Exp YoY | Exp % of Ch. 30 | Imports (₹ Cr) | Imp share | Imp YoY | Imp % of Ch. 30 | Trade balance | Exp rank |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| FY 2018-19 | 2,183.45 | 0.0951% | — | 2.11% | 497.86 | 0.0139% | — | 3.41% | +1,685.59 | #178 |
| FY 2019-20 | 2,229.08 | 0.1009% | +2.09% | 1.93% | 484.90 | 0.0145% | −2.60% | 2.93% | +1,744.18 | #168 |
| FY 2020-21 | 2,635.32 | 0.1225% | +18.22% | 1.83% | 514.83 | 0.0177% | +6.17% | 2.72% | +2,120.49 | #155 |
| FY 2021-22 | 3,159.26 | 0.1007% | +19.88% | 2.19% | 1,022.65 | 0.0224% | +98.64% | 3.99% | +2,136.61 | #171 |
| FY 2022-23 | 3,092.53 | 0.0854% | −2.11% | 1.94% | 880.45 | 0.0153% | −13.91% | 4.19% | +2,212.08 | #180 |
| FY 2023-24 | 2,923.87 | 0.0808% | −5.45% | 1.60% | 893.45 | 0.0159% | +1.48% | 4.17% | +2,030.42 | #190 |
| FY 2024-25 | 2,750.49 | 0.0743% | −5.93% | 1.32% | 961.47 | 0.0158% | +7.61% | 3.81% | +1,789.02 | #212 |

- CAGR (7-year): exports 3.92%/yr, imports 11.59%/yr (consistently Surplus)

## Key trade insights: HSN Sub-Chapter 3003 export-import analysis

### Consistent export growth: 3.92% CAGR over 7 years

India's exports under HSN Sub-Chapter 3003 have grown at a compound annual rate of 3.92% over 7 fiscal years, rising from ₹2,183.45 Crore in FY 2018-19 to ₹2,750.49 Crore in FY 2024-25.

### HSN Sub-Chapter 3003 ranked #212 among all 1233 sub-chapters by export value

In FY 2024-25, HSN Sub-Chapter 3003 ranks #212 out of 1233 sub-chapters by total export value. Within Chapter 30, it ranks #3 of 6. By trade surplus, it ranks #140 of 1233.

### FY 2021-22 was the strongest growth year for HSN Sub-Chapter 3003 exports

The strongest single-year export movement for HSN Sub-Chapter 3003 was recorded in FY 2021-22, when exports surged by 19.88% over the prior year.

### India maintains a trade surplus of ₹1,789.02 Crore in HSN Sub-Chapter 3003 goods

In FY 2024-25, India's exports of ₹2,750.49 Cr exceeded imports of ₹961.47 Cr, resulting in a trade surplus of ₹1,789.02 Crore — ranking #140 of 1233 by surplus magnitude.

### Import growth of 11.59% CAGR signals rising demand for Mixed medicaments, therapeutic use

India's imports under HSN Sub-Chapter 3003 have grown at 11.59% CAGR, reaching ₹961.47 Crore in FY 2024-25.

### HSN Sub-Chapter 3003 contributes 1.32% of Chapter 30 exports — ranked #3

Among the 6 sub-chapters under Chapter 30, HSN Sub-Chapter 3003 ranks #3 by export value — accounting for 1.32% of the chapter's total exports in FY 2024-25. On the import side, it holds 3.81% share (rank #4).

## Related Sub-Chapters in Chapter 30

Ranked by export value (FY 2024-25).

| Rank | HSN Sub-Chapter | Exports (FY 2024-25) |
| --- | --- | --- |
| #1 | [HSN Sub-Chapter 3004: Medicaments for therapeutic uses](https://busy.in/hsn/sub-chapter-3004/) | ₹1,86,519 Cr |
| #2 | [HSN Sub-Chapter 3002: Human & animal blood prepared](https://busy.in/hsn/sub-chapter-3002/) | ₹15,063 Cr |
| #3 | HSN Sub-Chapter 3003: Mixed medicaments, therapeutic use (this hsn sub-chapter) | ₹2,750 Cr |
| #4 | [HSN Sub-Chapter 3006: Pharmaceutical goods](https://busy.in/hsn/sub-chapter-3006/) | ₹2,519 Cr |
| #5 | [HSN Sub-Chapter 3005: Wadding & gauze for medical purposes](https://busy.in/hsn/sub-chapter-3005/) | ₹801 Cr |
| #6 | [HSN Sub-Chapter 3001: Organotherapeutic extracts & heparin](https://busy.in/hsn/sub-chapter-3001/) | ₹476 Cr |

## Other sub-chapters

| Code | Title |
| --- | --- |
| 3001 | [Organotherapeutic extracts & heparin](https://busy.in/hsn/sub-chapter-3001/) |
| 3002 | [Human & animal blood prepared](https://busy.in/hsn/sub-chapter-3002/) |
| 3004 | [Medicaments for therapeutic uses](https://busy.in/hsn/sub-chapter-3004/) |
| 3005 | [Wadding & gauze for medical purposes](https://busy.in/hsn/sub-chapter-3005/) |
| 3006 | [Pharmaceutical goods](https://busy.in/hsn/sub-chapter-3006/) |